MOMINA SHAHID1, KANWAL REHMAN2, MUHAMMAD SAJID HAMID AKASH1,*, SHALEEM SUHAIL1, SUMBAL RASHEED1, MUHAMMAD IMRAN3,4, MOHAMMED A. ASSIRI3,4
BIOCELL, Vol.47, No.3, pp. 473-484, 2023, DOI:10.32604/biocell.2023.025930
- 03 January 2023
Abstract Genetic polymorphism has a vital role in the pathogenesis and development of myocardial infarction (MI). Single nucleotide polymorphism at any one of the amino acid sequences can result in a diseased state. A single gene can exhibit genetic polymorphism at more than one position giving rise to different variants. Genetic polymorphism of angiotensinogen (AGT) M235T, AGT T174M, and angiotensin-1-converting enzyme (ACE) I/D, endothelial nitric oxide synthase (eNOS), and methylenetetrahydrofolate reductase (MTHFR) can be a risk factor for MI. However, it is important to study the prevalence of genetic polymorphisms of these genes among different populations. More >
Login
Register
